The tru Shrimp Companies announced that tr Shrimp has appointed Hawkins as the exclusive distributor of its tru Chitosan products into the US’ pharmaceutical and medical device industries. tru Chitosan is derived from the exoskeletons of tru Shrimp’s production of consumer shrimp. Chitosan is a molecule refined from the shell of shrimp and is used for numerous pharmaceutical and medical applications. tru Shrimp is the only United States producer of chitosan that meets the strict medical specifications of the United States Pharmacopoeia – National Formulary monograph. The shrimp are grown indoors under controlled conditions free of pollution, disease, preserving chemicals, and antibiotics.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on HWKN:
- Hawkins upgraded to Buy from Neutral at BWS Financial
- Hawkins (HWKN) Announces Q3 Dividend: Read On for Important Dates
- Hawkins increases quarterly dividend to 16c per share
- Hawkins, Inc. Reports First Quarter Fiscal 2024 Results
- Hawkins, Inc. Increases Quarterly Cash Dividend by 7% to $0.16 Per Share
